Cimavax-EGF, the only one of its kind in the world,
received the authorization from the Chinese State Food and Drug
Administration (SFDA) to begin clinical trials in the Asian nation
Cimavax-EGF, the only one of its kind in the world,
received the authorization from the Chinese State Food and Drug
Administration (SFDA) to begin clinical trials in the Asian nation